Novavax
NVAX
#5688
Rank
โ‚น124.38 B
Marketcap
โ‚น753.83
Share price
-5.45%
Change (1 day)
25.01%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -โ‚น20.13 Billion

According to Novavax's latest financial reports the company's current earnings are โ‚น0.41 Billion. In 2025 the company made an earning of โ‚น43.46 Billion, an increase over its 2024 earnings that were of -โ‚น14.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น20.13 Billion-146.3%
2025 โ‚น43.46 B-396.87%
2024 -โ‚น14.65 Billion-70.39%
2023 -โ‚น49.44 Billion-16.59%
2022 -โ‚น59.28 Billion-62.58%
2021 -โ‚น158.42 Billion320.54%
2020 -โ‚น37.67 Billion234.22%
2019 -โ‚น11.28 Billion-30.17%
2018 -โ‚น16.14 Billion1.69%
2017 -โ‚น15.88 Billion-36.44%
2016 -โ‚น24.98 Billion70.4%
2015 -โ‚น14.66 Billion89.27%
2014 -โ‚น7.75 Billion59.83%
2013 -โ‚น4.85 Billion81.9%
2012 -โ‚น2.67 Billion50.33%
2011 -โ‚น1.78 Billion
2009 -โ‚น3.5 Billion8.8%
2008 -โ‚น3.22 Billion18.01%
2007 -โ‚น2.73 Billion18.33%
2006 -โ‚น2.31 Billion168.31%
2005 -โ‚น0.86 Billion-62.51%
2004 -โ‚น2.29 Billion52.4%
2003 -โ‚น1.51 Billion-28.21%
2002 -โ‚น2.1 Billion
2000 -โ‚น1.2 Billion177%
1999 -โ‚น0.44 Billion-11.54%
1998 -โ‚น0.49 Billion10.64%
1997 -โ‚น0.44 Billion-9.62%
1996 -โ‚น0.49 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.182 T-5,758.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น651.69 B-3,218.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.411 T-6,853.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น669.13 B-3,302.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚น12.25 Billion-41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น30.48 Billion 45.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น14.12 B-167.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น0.77 Billion-96.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น33.18 Billion 58.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น18.21 Billion-12.90%๐Ÿ‡บ๐Ÿ‡ธ USA